376
Participants
Start Date
June 30, 2016
Primary Completion Date
February 29, 2024
Study Completion Date
June 30, 2029
Transcatheter aortic valve replacement
Retrograde transfemoral transcatheter aortic valve replacement with any CE mark approved aortic bioprosthesis with or without concomitant percutaneous coronary intervention.
Surgical aortic valve replacement
Conventional surgical aortic valve replacement with a bioprosthesis using normothermic cardiopulmonary bypass and cold blood cardioplegia cardiac arrest with or without concomitant coronary artery bypass graft surgery.
Landspital, Reykjavik
Rigshospitalet, Copenhagen University Hospital, Copenhagen
Haukeland University Hospital, Bergen
Aarhus University hospital, Aarhus
Turku University Hospital, Turku
Oulu University Hospital, Oulu
Helsinki University Central Hospital, Helsinki
Sahlgrenska University Hospital, Gothenburg
Karolinska University Hospital, Stockholm
Collaborators (3)
Symetis SA
INDUSTRY
Boston Scientific Corporation
INDUSTRY
Abbott
INDUSTRY
Edwards Lifesciences
INDUSTRY
Ole De Backer
OTHER